ENACT-aMCI: ENgaging in Advance Care Planning Talks Group Visit Intervention for Cognitive Impairment

Sponsor
University of Colorado, Denver (Other)
Overall Status
Completed
CT.gov ID
NCT03711396
Collaborator
(none)
26
2
2
23.5
13
0.6

Study Details

Study Description

Brief Summary

The Advance Care Planning Group Visit intervention is a new intervention that uses the strengths of group visits to promote advance care planning conversations and documentation. However, the Advance Care Planning Group Visit intervention was initially designed for individuals without cognitive impairment. This study will specifically investigate ways to adapt the Advance Care Planning Group Visit intervention for individuals with amnestic Mild Cognitive Impairment and their family care partners.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Advance Care Planning Group Visits
N/A

Detailed Description

Advance care planning is a process that supports adults at any age or stage of health in understanding and sharing their personal values, life goals, and preferences regarding future medical care. The goal of advance care planning is to help ensure that people receive medical care that is consistent with their values, goals and preferences during serious and chronic illness.

The Advance Care Planning Group Visit intervention is a new intervention that uses the strengths of group visits to promote advance care planning conversations and documentation. However, the Advance Care Planning Group Visit intervention was initially designed for individuals without cognitive impairment. This study will specifically investigate ways to adapt the Advance Care Planning Group Visit intervention for individuals with amnestic Mild Cognitive Impairment.

This is a pilot test of the Advance Care Planning Group Visit intervention adaptations, called ENgaging in Advance Care planning Talks Group Visit intervention (ENACT Memory Group Visits), to see if it is feasible, acceptable and improves the number of people with amnestic mild cognitive impairment who complete an advance directive (a legal form that describes someone's wishes for future medical care if they are unable to make their own decisions). It will also see how ready individuals are to participate in advance care planning. The overall goal is to improve opportunities for older adults with amnestic mild cognitive impairment to receive medical care that is consistent with their values, goals, and preferences.

This aim will use rapid-cycle prototyping (n-of-1 interventions) to conduct the ENgaging in Advance Care planning Talks (ENACT) Memory Group Visits, adapting them for individuals with amnestic Mild Cognitive Impairment. Each n-of-1 prototype will include up to 10 patient-study partner dyads meeting in up to two 2-hour group medical visit sessions, one month apart. Four cohorts will be conducted so that approximately 40 participants are involved in the n-of-1 prototypes of the ENACT Memory Group Visit intervention. The intervention will be conducted based on an intervention manual that will be refined and adapted with input from patients, study partners, and the research team of multidisciplinary clinicians. Participants will receive the Colorado Medical Durable Power of Attorney form and other appropriate advance care planning resources for individuals with aMCI.

Study Design

Study Type:
Interventional
Actual Enrollment :
26 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Intervention Model Description:
We will conduct four n-of-1 group visit interventions for advance care planning.We will conduct four n-of-1 group visit interventions for advance care planning.
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
ENgaging in Advance Care Planning Talks Group Visit Intervention (ENACT) for Individuals With Amnestic Mild Cognitive Impairment (aMCI)
Actual Study Start Date :
Feb 1, 2019
Actual Primary Completion Date :
Oct 31, 2020
Actual Study Completion Date :
Jan 15, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Advance Care Planning Group Visits - amnestic Mild Cognitive Impairment

Participants with amnestic Mild Cognitive Impairment will attend group visits to discuss advance care planning with their study partners. Group visits will last up to two hours and be help up to twice.

Behavioral: Advance Care Planning Group Visits
Pilot test the Advance Care Planning Group Visit intervention adaptations, called ENgaging in Advance Care planning Talks Group Visit intervention (ENACT Memory Group Visits), to see if it is feasible, acceptable and improves the number of people with amnestic mild cognitive impairment who complete an advance directive (a legal form that describes someone's wishes for future medical care if they are unable to make their own decisions). It will also see how ready individuals are to participate in advance care planning. The overall goal is to improve opportunities for older adults with amnestic mild cognitive impairment to receive medical care that is consistent with their values, goals, and preferences.

Experimental: Advance Care Planning Group Visits - Care Partners

Care partners of persons with amnestic Mild Cognitive Impairment will attend group visits, with the person with Mild Cognitive Impairment, to discuss advance care planning. Group visits will last up to two hours and be help up to twice.

Behavioral: Advance Care Planning Group Visits
Pilot test the Advance Care Planning Group Visit intervention adaptations, called ENgaging in Advance Care planning Talks Group Visit intervention (ENACT Memory Group Visits), to see if it is feasible, acceptable and improves the number of people with amnestic mild cognitive impairment who complete an advance directive (a legal form that describes someone's wishes for future medical care if they are unable to make their own decisions). It will also see how ready individuals are to participate in advance care planning. The overall goal is to improve opportunities for older adults with amnestic mild cognitive impairment to receive medical care that is consistent with their values, goals, and preferences.

Outcome Measures

Primary Outcome Measures

  1. Change in Readiness to Engage in ACP (ACP Engagement Scale) [0, 3 months]

    The Advance Care Planning (ACP) Engagement Scale will be used to assess readiness to engage in specific parts of the advance care planning process (i.e. signing official papers to name a medical decision maker; talking to the decision maker; talking to the doctor; signing official papers putting their wishes in writing). Items are rated on a Likert scale, with possible scores ranging from 1-5. Higher scores indicate a higher level of engagement with the advance care planning behavior and a better outcome.

Secondary Outcome Measures

  1. Change in Readiness to Engage in ACP (ACP Engagement Score) - Care Partner Reported [0, 3 months]

    Care partner report of the Advance Care Planning (ACP) Engagement Scale will be used to assess care partner perspectives on the person with amnestic mild cognitive impairment's readiness to engage in specific parts of the advance care planning process (i.e. signing official papers to name a medical decision maker; talking to the decision maker; talking to the doctor; signing official papers putting their wishes in writing). Items are rated on a Likert scale, with possible scores ranging from 1-5. Higher scores indicate a higher level of engagement with the advance care planning behavior and a better outcome.

Other Outcome Measures

  1. Advance Care Planning Intervention Evaluation [Following Session Participation, 15 minutes after completed]

    Investigator-developed 7-item evaluation to assess participant rating of intervention comfort in the group setting, usefulness, preference compared to one-on-one visits, and helpfulness of talking with others. Each item is rated from "strong disagree" to "strongly agree" on a 5-point Likert scale. Scores can range from 1-5 with a score of 5 being a better outcome. This scale has not been specifically named. It has been published in the included reference.

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • diagnosis of amnestic mild cognitive impairment

  • ability to provide consent

  • have a study partner who has regular interaction with the patient

Exclusion Criteria:
  • known prior diagnosis of deafness/hearing loss that would limit group discussion participation

  • inability to travel to study location

  • not having access to a phone for follow up

  • not having an individual who is able to serve as a study partner to the patient

  • normal cognitive screen based on SPMSQ

Contacts and Locations

Locations

Site City State Country Postal Code
1 UCHealth Aurora Colorado United States 80045
2 University of Colorado Anschutz Medical Campus Aurora Colorado United States 80045

Sponsors and Collaborators

  • University of Colorado, Denver

Investigators

None specified.

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT03711396
Other Study ID Numbers:
  • 18-1459
First Posted:
Oct 18, 2018
Last Update Posted:
Nov 22, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Colorado, Denver
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Advance Care Planning Group Visits - aMCI Advance Care Planning Group Visits - Care Partners
Arm/Group Description Participants with amnestic mild cognitive impairment (aMCI) will attend group visits to discuss advance care planning with their study partners. Group visits will last up to two hours and be held up to twice. Participants who are the care partners of persons with amnestic mild cognitive impairment (aMCI) will attend group visits (with the person with aMCI) to discuss advance care planning with their study partners. Group visits will last up to two hours and be held up to twice.
Period Title: Overall Study
STARTED 13 13
COMPLETED 13 13
NOT COMPLETED 0 0

Baseline Characteristics

Arm/Group Title Intervention
Arm/Group Description Participants attended two group visits one month apart to discuss advance care planning and to receive information about advance care planning.
Overall Participants 13
Age (Count of Participants)
<=18 years
0
0%
Between 18 and 65 years
0
0%
>=65 years
13
100%
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
78.7
(5.8)
Sex: Female, Male (Count of Participants)
Female
3
23.1%
Male
10
76.9%
Ethnicity (NIH/OMB) (Count of Participants)
Hispanic or Latino
1
7.7%
Not Hispanic or Latino
12
92.3%
Unknown or Not Reported
0
0%
Race (NIH/OMB) (Count of Participants)
American Indian or Alaska Native
0
0%
Asian
0
0%
Native Hawaiian or Other Pacific Islander
0
0%
Black or African American
1
7.7%
White
10
76.9%
More than one race
0
0%
Unknown or Not Reported
2
15.4%
Region of Enrollment (Count of Participants)
United States
13
100%
Education (Count of Participants)
High School Graduate
3
23.1%
Some College
1
7.7%
College Graduate
2
15.4%
Any Post-graduate
7
53.8%
Relationship status (Count of Participants)
Married/with partner
10
76.9%
Widowed
1
7.7%
Divorced/separated
2
15.4%
Caregiver in the last 12 months (Count of Participants)
Yes
2
15.4%
No
11
84.6%
Self-Rated Health (Count of Participants)
Excellent
8
61.5%
Good
3
23.1%
Fair
2
15.4%
Poor
0
0%
Very Poor
0
0%
Relationship of Study Partner to Participant (Count of Participants)
Spouse
9
69.2%
Partner
1
7.7%
Child
3
23.1%

Outcome Measures

1. Primary Outcome
Title Change in Readiness to Engage in ACP (ACP Engagement Scale)
Description The Advance Care Planning (ACP) Engagement Scale will be used to assess readiness to engage in specific parts of the advance care planning process (i.e. signing official papers to name a medical decision maker; talking to the decision maker; talking to the doctor; signing official papers putting their wishes in writing). Items are rated on a Likert scale, with possible scores ranging from 1-5. Higher scores indicate a higher level of engagement with the advance care planning behavior and a better outcome.
Time Frame 0, 3 months

Outcome Measure Data

Analysis Population Description
Participants with aMCI
Arm/Group Title Advance Care Planning Group Visits - Persons With aMCI
Arm/Group Description Participants with amnestic Mild Cognitive Impairment will attend group visits to discuss advance care planning with their study partners. Group visits will last up to two hours and be help up to twice.
Measure Participants 13
Readiness to sign official papers naming a medical decision maker at 0 months
1.92
(1.12)
Readiness to talk to decision maker at 0 months
1.54
(0.88)
Readiness to talk to doctor at 0 months
2.77
(1.36)
Readiness to sign papers putting wishes into writing at 0 months
2.00
(1.15)
Readiness to sign official papers naming a medical decision maker at 3 months
1.77
(0.93)
Readiness to talk to decision maker at 3 months
2.38
(0.96)
Readiness to talk to doctor at 3 months
2.00
(0.91)
Readiness to sign papers putting wishes into writing at 3 months
2.08
(1.16)
2. Secondary Outcome
Title Change in Readiness to Engage in ACP (ACP Engagement Score) - Care Partner Reported
Description Care partner report of the Advance Care Planning (ACP) Engagement Scale will be used to assess care partner perspectives on the person with amnestic mild cognitive impairment's readiness to engage in specific parts of the advance care planning process (i.e. signing official papers to name a medical decision maker; talking to the decision maker; talking to the doctor; signing official papers putting their wishes in writing). Items are rated on a Likert scale, with possible scores ranging from 1-5. Higher scores indicate a higher level of engagement with the advance care planning behavior and a better outcome.
Time Frame 0, 3 months

Outcome Measure Data

Analysis Population Description
Care partners of persons with aMCI
Arm/Group Title Advance Care Planning Group Visits - Care Partners
Arm/Group Description Care partners of persons with amnestic mild cognitive impairment who participated in the advance care planning group visits.
Measure Participants 13
Readiness to sign official papers naming a medical decision maker at 0 months
1.92
(1.19)
Readiness to talk to decision maker at 0 months
2.31
(1.25)
Readiness to talk to doctor at 0 months
2.62
(0.96)
Readiness to sign papers putting wishes into writing at 0 months
1.62
(0.77)
Readiness to sign official papers naming a medical decision maker at 3 months
1.69
(1.11)
Readiness to talk to decision maker at 3 months
2.54
(0.88)
Readiness to talk to doctor at 3 months
1.77
(.93)
Readiness to sign papers putting wishes into writing at 3 months
1.92
(0.95)
3. Other Pre-specified Outcome
Title Advance Care Planning Intervention Evaluation
Description Investigator-developed 7-item evaluation to assess participant rating of intervention comfort in the group setting, usefulness, preference compared to one-on-one visits, and helpfulness of talking with others. Each item is rated from "strong disagree" to "strongly agree" on a 5-point Likert scale. Scores can range from 1-5 with a score of 5 being a better outcome. This scale has not been specifically named. It has been published in the included reference.
Time Frame Following Session Participation, 15 minutes after completed

Outcome Measure Data

Analysis Population Description
Combined persons with aMCI and care partners groups
Arm/Group Title Advance Care Planning Group Visits - Amnestic Mild Cognitive Impairment Advance Care Planning Group Visits - Care Partners
Arm/Group Description Participants with aMCI completed an evaluation of the intervention prototype. Care partners of persons with amnestic Mild Cognitive Impairment who participated in the advance care planning group visits.
Measure Participants 13 13
Group setting is better for ACP discussion than normal doctor visit
4.23
(1.09)
4.69
(0.48)
The group discussion gave me useful information
4.62
(0.51)
5.00
(0.00)
I felt comfortable talking about ACP in the group setting
4.54
(0.66)
4.92
(0.28)
Talking with other people about ACP was helpful
4.23
(1.36)
5.00
(0.00)
I feel the group visit addressed my specific questions
4.31
(0.75)
4.46
(0.66)
I feel able to discuss ACP with my regular healthcare provider
4.62
(0.51)
4.38
(0.65)
I would recommend these group visit sessions to a friend
4.38
(1.45)
4.92
(0.28)

Adverse Events

Time Frame 3 months
Adverse Event Reporting Description
Arm/Group Title Advance Care Planning Group Visits
Arm/Group Description Participants will attend group visits to discuss advance care planning with their study partners. Group visits will last up to two hours and be help up to twice. Advance Care Planning Group Visit: Aim 1: The first part of this study will focus on refining and adapting the Advance Care Planning Group Visit intervention so that it meets the needs of persons with amnestic cognitive impairment and a study partner who participates with them. Aim 2: The second part of the study will pilot test the Advance Care Planning Group Visit intervention adaptations, called ENgaging in Advance Care planning Talks Group Visit intervention (ENACT Memory Group Visits), to see if it is feasible, acceptable and improves the number of people with amnestic mild cognitive impairment who complete an advance directive (a legal form that describes someone's wishes for future medical care if they are unable to make their own decisions). It will also see how ready individuals are to participate in advance care planning. The overall goal is to improve opportunities for older adults with amnestic mild cognitive impairment to receive medical care that is consistent with their values, goals, and preferences.
All Cause Mortality
Advance Care Planning Group Visits
Affected / at Risk (%) # Events
Total 0/13 (0%)
Serious Adverse Events
Advance Care Planning Group Visits
Affected / at Risk (%) # Events
Total 0/13 (0%)
Other (Not Including Serious) Adverse Events
Advance Care Planning Group Visits
Affected / at Risk (%) # Events
Total 0/13 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. Hillary D. Lum
Organization University of Colorado School of Medicine
Phone 303-724-1911
Email hillary.lum@cuanschutz.edu
Responsible Party:
University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT03711396
Other Study ID Numbers:
  • 18-1459
First Posted:
Oct 18, 2018
Last Update Posted:
Nov 22, 2021
Last Verified:
Oct 1, 2021